Nucleated red blood cells in the blood of medical intensive care patients indicate increased mortality risk: a prospective cohort study
Open Access
- 5 June 2007
- journal article
- Published by Springer Nature in Critical Care
- Vol. 11 (3) , R62
Abstract
Introduction: In critically ill patients, the appearance of nucleated red blood cells (NRBCs) in blood is associated with a variety of severe diseases. Generally, when NRBCs are detected in the patients' blood, the prognosis is poor. Methods: In a prospective study, the detection of NRBCs was used for a daily monitoring of 383 medical intensive care patients. Results: The incidence of NRBCs in medical intensive care patients was 17.5% (67/383). The mortality of NRBC-positive patients was 50.7% (34/67); this was significantly higher (p < 0.001) than the mortality of NRBC-negative patients (9.8%, 31/316). Mortality increased with increasing NRBC concentration. Seventy-eight point six percent of the patients with NRBCs of more than 200/μl died. The detection of NRBCs is highly predictive of death, the odds ratio after adjustment for other laboratory and clinical prognostic indicators being 1.987 (p < 0.01) for each increase in the NRBC category (0/μl, 1 to 100/μl, 101 to 200/μl, and more than 200/μl). Each step-up in the NRBC category increased the mortality risk as much as an increase in APACHE II (Acute Physiology and Chronic Health Evaluation II) score of approximately 4 points. The mortality of patients who were NRBC-positive on the day of relocation from the intensive care unit to a peripheral ward was 27.6% (8/27). This was significantly higher than the mortality of patients who were NRBC-negative on the relocation day (8.6%, 28/325; p < 0.01). On average, NRBCs were detected for the first time 14 days (median, 3 days) before death. Conclusion: The routine analysis of NRBCs in blood is of high prognostic power with regard to mortality of critically ill patients. Therefore, this parameter may serve as a daily indicator of patients at high mortality risk. Furthermore, NRBC-positive intensive care patients should not be relocated to a normal ward but should obtain ongoing intensive care treatment.Keywords
This publication has 39 references indexed in Scilit:
- Daily monitoring of nucleated red blood cells in the blood of surgical intensive care patientsClinica Chimica Acta, 2006
- Persistent nucleated red blood cells in peripheral blood is a poor prognostic factor in patients undergoing stem cell transplantationClinical and Laboratory Haematology, 2005
- High in-hospital mortality of intensive care patients with nucleated red blood cells in bloodClinical Chemistry and Laboratory Medicine (CCLM), 2004
- Prognostic Significance of the Presence of Erythroblasts in Blood after Cardiothoracic SurgeryClinical Chemistry and Laboratory Medicine (CCLM), 2001
- A Multicenter, Randomized, Controlled Clinical Trial of Transfusion Requirements in Critical CareNew England Journal of Medicine, 1999
- A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter studyJAMA, 1993
- Normoblastemia after thermal injuryThe American Journal of Surgery, 1976
- The Association of Nucleated Red Cells in the Peripheral Smear with HypoxemiaAnnals of Internal Medicine, 1967
- LEUCO-ERYTHROBLASTOSIS IN THE ADULTThe Lancet, 1964
- Myelophthisic anemia in cancer of the breastThe American Journal of Medicine, 1955